Patient Heterogeneity in CD

Slides:



Advertisements
Similar presentations
Immunomodulators and Biologics Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida.
Advertisements

Thiopurines still have a role in the management of pediatric IBD Athos Bousvaros MD, MPH Associate Director, IBD program Boston Children’s Hospital.
Vedolizumab in Pediatric IBD: We are Ready to Use It
1 Top-Down vs Step-Up Trial Endoscopic Substudy: Mucosal Healing Patients, % P
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
The Nurse’s Role in Inflammatory Bowel Disease
The Nurse View: Management of Pancreatic Cancer
Clinical Trials in IBD.
How the Latest Data in MDD Can Guide Treatment Decisions:
IL-12 and IL-23.
Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.
Strategies for Mucosal Healing in Crohn Disease
Goals of Therapy for Patients With UC
Optimizing Use of Biological Agents in Ulcerative Colitis
Changing the IBD Paradigm
The Genomics of Cancer and Molecular Testing:
Volume 138, Issue 2, Pages (February 2010)
Goals of Therapy in Relapsed CLL
Comparing Treatment Alternatives in Ankylosing Spondylitis
Optimizing Patient Outcomes in IBD
Pathways in Managing Ulcerative Colitis
IL-17 Inhibitors in the Management of Psoriatic Disease
Decision-making in the eRA of Treating to Target
PAH Therapy Revisited.
Are We Closer to Personalized Medicine in MS?
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.
Case Collection in RA: Highlights of an Interactive Workshop
Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.
Managing IBD.
Program Goals. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer.
Atopic Dermatitis. Introduction to a Clinical Course On New Developments In Atopic Dermatitis.
Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors
Ask the Experts.
Evolving Treatment Landscape for PsA
Illustrations in Ulcerative Colitis
Debating the Issues in Rheumatoid Arthritis with the Experts: Early Treatment and Targets.
Advancing the Treatment of IBD With Biologics
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists 
Treating CD30-Expressing Cutaneous T-Cell Lymphoma
Advances in Multiple Myeloma: Data Highlights and Analysis from the 2015 Hematology/Oncology Conferences.
Best Clinical Pearls in Hidradenitis Suppurativa:
Early Referral for Patients With IBD Failing Conventional Therapies
Advancing Patient Care in RA
When Is Intrathecal Drug Delivery Appropriate?
Cancer-Associated Thrombosis
Viewpoints of Practicing Rheumatologists: Case Discussions in RA
Miguel Regueiro, Kevin E. Kip, Leonard Baidoo, Jason M
Optimizing Outcomes in Crohn Disease
Are We Making Progress in the Management of Huntington Disease?
Application of Biologics in IBD:
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases 
Essential Updates for PsA: A Complex Disease to Manage
When Is Intrathecal Drug Delivery Appropriate?
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Pathogenesis of IBD, and the Role of Biologic Therapies
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Targeting IL-23 for Therapeutic Longevity in Psoriasis
A Closer Look.
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease  Guillaume Bouguen, Barrett G.
Presentation data from US VICTORY Consortium
Presentation data from US VICTORY Consortium
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Crohn’s Disease Biologic Pathway
The Future Is Now: Gene Therapy for Inherited Retinal Diseases
Comparative Studies of Biologics in Ulcerative Colitis
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
The Power of As-Treated Analyses
Meet the JAKs.
Women With Psoriasis Are Struggling More Than Men
Presentation transcript:

Patient Heterogeneity in CD

Individualized Predictive Markers for Severe CD

Tight Monitoring and Treat-to-Target Approach: CALM Trial

Biologic Therapy for CD

Anti-TNF: Mucosal Healing in CD

Ustekinumab: Mucosal Healing in CD

Vedolizumab: Endoscopic Healing and Remission in CD

VICTORY Consortium: Vedolizumab vs Anti-TNF Therapy (Propensity Score Matched Analysis)

Vedolizumab Safety Profile: Data From the GEMINI2 Trial

Ustekinumab Safety Profile: Data From the UNITI-2 Trial

Monitoring Patients: Beyond Clinical Symptoms

Abbreviations

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.